Skip to main content

VE.TO

ETF
—
—

Performance overview

VE.TO Price
Price Chart

Forward-looking statistics

Beta
0.84
Risk
14.92%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodActively Managed
DiversifiedYes
Expense ratio0.10%
Asset classUnknown

Top holdings

Novo Nordisk AS Class B3.27%
ASML Holding NV2.72%
Nestle SA2.16%
AstraZeneca PLC2.01%
Novartis AG Registered Shares1.88%
SAP SE1.84%
Roche Holding AG1.80%
Shell PLC1.73%
Lvmh Moet Hennessy Louis Vuitton SE1.41%
Other81.19%

Sector exposure

Financial Services18.25%
Industrials17.34%
Healthcare15.95%
Consumer Defensive9.78%
Consumer Cyclical9.41%
Technology8.38%
Basic Materials6.70%
Energy5.02%
Communication Services3.65%
Other5.51%

Country exposure

UK22.48%
Switzerland15.44%
France14.69%
Germany12.51%
Netherlands7.47%
Sweden5.67%
Denmark5.34%
Italy4.32%
Spain4.18%
Other7.90%

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeToronto Stock Exchange
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$580K
Avg trading volume (10 day)$587K
Put-call ratioN/A

Macro factor sensitivity

Growth+0.2
Credit+2.1
Liquidity+0.0
Inflation-1.5
Commodities-0.5
Interest Rates-1.1

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayJune 20, 2025

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free